ArticleFASEB bioAdvances2020

Anti-ORAI1 antibody DS-2741a, a specific CRAC channel blocker, shows ideal therapeutic profiles for allergic disease via suppression of aberrant T-cell and mast cell activation.

Anri Aki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.